Bcm-95 Curcumin — Why Bioavailability Is Everything
Quick Read Standard curcumin supplements are poorly absorbed by your body because curcumin doesn’t dissolve well in water and is
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Magnesium L-threonate (MgT) is a form of magnesium designed to cross into the brain more effectively than standard magnesium supplements. Most magnesium types struggle to reach brain tissue, but the threonate component appears to help it get there. Once in the brain, magnesium plays a key role in memory, learning, and helping neurons form stronger connections, particularly by activating receptors called NMDA receptors that are central to how we learn new things.
Animal research shows consistent benefits: rats given MgT showed better memory, improved ability to distinguish between similar situations, and reduced age-related cognitive decline. In mouse models of Alzheimer’s disease, MgT prevented synapse loss and reversed memory problems, though these findings from animal studies don’t automatically translate to humans. Two human trials have emerged recently. A 2025 study of 100 adults showed that six weeks of MgT led to faster reaction time, better working memory, and an estimated 7.5-year reduction in cognitive age compared to placebo, alongside improved sleep quality and reduced stress markers. A 2022 study of 109 Chinese adults found improvements across all five memory test categories after 30 days, with older participants showing greater gains.
The evidence for sleep improvement is promising but mixed: one small trial found significant objective sleep improvements, while another found mainly subjective benefits and improved stress markers rather than sleep architecture changes. The human trial base remains small and short-term, typically 6-12 weeks in adults under 65, so larger, longer studies are needed. Magnesium is water-soluble with no toxicity risk at the doses used (1-2 grams daily), and deficiency is common in Western populations.
Verdict: Magnesium L-threonate shows genuine promise for memory, reaction speed, and sleep quality based on early human trials and consistent animal research, but evidence remains preliminary and larger, longer-term studies are needed before making definitive claims.
What if the reason your standard magnesium supplement isn’t helping your brain is simply that it can’t get there? Not because magnesium doesn’t matter for cognition, it absolutely does, but because most forms of magnesium struggle to cross the blood-brain barrier in meaningful amounts. That’s the central question behind magnesium L-threonate, a compound specifically engineered to solve that problem. And the research, while still maturing, is quietly compelling. At Vitacuity, we’ve reviewed over 1.77 million research papers and selected the most relevant ones on this topic. Here’s what the evidence actually shows, the strong findings, the promising early signals, and the honest gaps.
Magnesium is not a single thing. It’s a mineral that can be bound to dozens of different molecules, oxide, citrate, glycinate, sulphate, chloride, and those different bonds change how the magnesium behaves in your body. Most forms are reasonably well absorbed in the gut, but relatively little makes it into the brain itself.
Magnesium L-threonate (MgT) was developed specifically to address this. The threonate component, a metabolite of vitamin C, appears to facilitate transport across the blood-brain barrier, meaning more magnesium actually reaches brain tissue and cerebrospinal fluid rather than just circulating in the bloodstream [5, 9].
Why does brain magnesium matter? Because magnesium is involved in an extraordinary range of neurological functions. It acts as a cofactor in over 300 enzymatic reactions, regulates ion channels, modulates synaptic plasticity, and plays a critical role in controlling NMDA receptors, the receptors at the heart of learning and memory [5]. Think of NMDA receptors as the gatekeepers of long-term potentiation: the process by which your brain strengthens connections between neurons when you learn something new.
Crucially, magnesium also regulates a specific subunit of the NMDA receptor called NR2B. This subunit tends to decline with age, and its reduction is closely associated with the loss of synaptic plasticity, the brain’s ability to adapt and rewire itself. Research suggests that elevating brain magnesium levels can upregulate NR2B expression, effectively nudging the ageing brain back towards a more youthful pattern of plasticity [12]. That’s the mechanism. Now let’s look at what the research actually shows when it’s tested in practice.
Evidence grade: Early stage, animal studies only for this specific finding
The story of MgT begins in 2010, when researchers at MIT published a landmark paper in *Neuron* showing that increasing brain magnesium using the newly developed MgT compound led to significant enhancements in learning ability, working memory, and both short- and long-term memory in rats [9].
The mechanism was striking: MgT-treated rats showed higher density of synaptophysin and synaptobrevin-positive puncta in the hippocampus, essentially, more active synaptic connections in the memory centres of the brain. Magnesium increased the number of functional presynaptic release sites and, coupled with upregulation of NR2B-containing NMDA receptors, enhanced synaptic plasticity. Aged rats showed particularly notable improvements in pattern completion ability [9].
This was the proof-of-concept moment. It established *why* MgT might be different, not just that magnesium matters, but that getting it *into* the brain changes what it can do. Everything that followed built on this foundation.
Evidence grade: Early stage, animal studies
Subsequent animal research added important layers to the picture. A 2011 study published in *The Journal of Neuroscience* showed that MgT treatment enhanced retention of fear extinction, helping rats let go of fearful associations more effectively, without erasing or impairing the original fear memory [15]. This is neurologically significant: the effect was region-specific, occurring in the prefrontal cortex but not the amygdala, suggesting MgT enhances the kind of flexible, contextual learning that allows emotional regulation without simply blunting fear responses.
A 2013 rat study extended this further, showing that MgT enhanced spatial-context pattern separation, the ability to distinguish between similar but distinct environments [11]. This is the cognitive faculty that allows you to remember that you parked in bay C3 yesterday but C7 today. It’s one of the earliest functions to decline with age and one of the most disruptive in daily life.
Across multiple animal studies, a consistent picture emerged: MgT doesn’t just boost overall memory non-specifically. It appears to sharpen the quality of memory, improving discrimination, flexibility, and the organisation of new learning.
Evidence grade: Early stage, mouse models of Alzheimer’s disease
Several studies have examined MgT in transgenic mouse models of Alzheimer’s disease, and the findings are striking, though it’s important to be clear that mouse models of AD are notoriously poor predictors of what works in humans.
A 2014 study published in *Molecular Brain* found that MgT treatment reduced amyloid-beta plaques, prevented synapse loss, and reversed cognitive deficits in APPswe/PS1dE9 mice, even when treatment began at the end-stage of Alzheimer’s-like pathological progression [14]. The mechanism appeared to involve stabilising BACE1 expression, restoring NMDA receptor signalling pathways, and preventing calcineurin overactivation, all of which are disrupted in Alzheimer’s disease.
A 2025 study in *Experimental Neurobiology* added another mechanism to the list: MgT appeared to ameliorate cognitive deficits in AD mice by promoting adult hippocampal neurogenesis, the growth of new neurons in the hippocampus, via activation of the ERK/CREB signalling pathway [2]. Newborn neurons gradually increased with MgT administration, correlating with improvements in maze performance.
A 2018 study went further still, showing that MgT boosted the memory-restorative effects of environmental enrichment in AD mice, suggesting the compound may work synergistically with cognitive stimulation [6].
These are genuinely interesting findings. But they are mouse findings. The leap from rodent Alzheimer’s models to human Alzheimer’s disease is large and fraught with failures. We include them because they illuminate *how* MgT might work, not as evidence that it prevents or treats Alzheimer’s in humans.
Evidence grade: Promising, one well-designed RCT, modest sample size
The most eye-catching human evidence comes from a 2025 randomised, double-blind, placebo-controlled trial published in *Frontiers in Nutrition* [1, 7]. One hundred adults aged 18 to 45 with self-reported dissatisfied sleep were given either 2g daily of Magtein® (a patented form of MgT) or a placebo for six weeks.
The results were notable. Compared to placebo, the MgT group showed:
– Greater improvement in overall cognitive performance as measured by the NIH Total Cognition Composite (p = 0.043), with particular effects on working and episodic memory – A 7.5-year reduction in estimated brain cognitive age, a composite measure based on cognitive test performance – Faster reaction time (p = 0.031) – Reduced resting heart rate (p = 0.030) and increased heart rate variability (p = 0.036) during sleep, both markers of improved autonomic balance and reduced physiological stress
There were also improvements in sleep-related impairment on self-report measures (p = 0.043), and in participants with more severe sleep problems, group differences in sleep disturbances were identified (p = 0.031). Objective sleep tracking via the Oura Ring showed no significant group differences in sleep architecture overall, though the autonomic improvements were real and measurable.
One test, Raven’s Progressive Matrices, a measure of fluid intelligence, showed no group difference (p = 0.953). MgT was well-tolerated with no significant adverse events.
This is encouraging data. But let’s be honest about what 100 participants over six weeks tells us: it’s a strong signal worth taking seriously, not a definitive answer. The sample skewed young (18-45), the trial was short, and we don’t know how these effects hold at longer timeframes or in older adults.
Evidence grade: Promising, one RCT, 109 participants, combined formula
A 2022 double-blind, placebo-controlled study published in *Nutrients* tested Magtein®PS, a formula combining MgT with phosphatidylserine and vitamins C and D, in 109 healthy Chinese adults aged 18–65 [8].
After 30 days at 2g/day, participants receiving the active formula showed significant improvements over placebo across all five subcategories of The Clinical Memory Test, a standardised cognitive assessment used in Chinese hospitals, as well as overall memory quotient scores. Notably, older participants showed greater improvements than younger ones.
The caveat here is the combination formula. Because the supplement contained phosphatidylserine alongside MgT, we can’t attribute all improvements solely to the magnesium L-threonate. This is a meaningful limitation. It’s promising data for the formula as a whole, but not clean evidence for MgT in isolation, and it’s worth stating honestly [8].
Evidence grade: Promising, two small RCTs, consistent subjective improvements, mixed objective data
A 2024 randomised controlled trial published in *Sleep Medicine: X* enrolled 80 adults aged 35–55 with self-assessed sleep problems and gave them either 1g/day of MgT or placebo for 21 days [10]. The findings were encouraging:
From objective Oura ring measurements, MgT significantly improved deep sleep score, REM sleep score, light sleep time, and multiple activity and readiness parameters compared to placebo. From subjective questionnaires, MgT significantly improved behaviour upon awakening, energy, daytime productivity, mood, and mental alertness.
The 2025 trial [1] found a more mixed picture on sleep, self-reported sleep impairment improved, but most objective sleep metrics on the Oura Ring did not show group differences. However, the autonomic markers (heart rate and HRV) did improve, and in the subgroup with more severe sleep issues, the pattern was clearer.
Taken together: there appears to be a real effect on sleep quality and daytime functioning, particularly for people with more significant sleep complaints, and particularly on deeper sleep stages and daytime energy. But the effect is not uniform across all measures, and it may depend on baseline severity. This is a pattern worth watching as more trials emerge.
Evidence grade: Early stage, animal studies, one new challenger in preclinical research
A 2019 rat study comparing MgT to magnesium chloride and magnesium sulphate found that MgT (at 100mg/kg) most significantly improved memory and reduced depression-like symptoms in healthy rats, and produced the greatest increase in plasma magnesium levels alongside improvements in cholinergic function and reductions in oxidative stress [13]. This supports the general view that the threonate form has advantages over simpler magnesium salts for brain-specific outcomes.
However, a 2026 preclinical study [3, 4], which has not yet been replicated in humans, found that a newer compound, magnesium acetyl-taurate (MAT), outperformed MgT on several markers of brain bioavailability, synaptic plasticity, and neuroinflammation in rats. The research suggests MAT achieved better magnesium levels in cerebrospinal fluid and brain tissue, and improved more biochemical markers of neurological function. MAT is an interesting emerging compound, but it has essentially no human trial data at this stage, and the comparison was in rodents only. MgT remains far better studied in humans.
The broader review literature [5] confirms that among available magnesium compounds, MgT and magnesium acetyl-taurate stand out for brain bioavailability, but MgT is currently the one with meaningful human evidence.
Let’s be genuinely honest about the gaps, because they’re significant.
The human trial base is thin. The most impactful human RCT [1] had 100 participants over six weeks, skewed young. The 2024 sleep trial [10] had 80 participants over 21 days. The 2022 study [8] used a combination formula. None of these are large, long-term trials. We don’t have a 500-person, 12-month RCT in adults over 50. That trial needs to happen.
The Alzheimer’s animal research doesn’t translate automatically. Mouse models of AD have repeatedly failed to produce human treatments. The neurogenesis and synapse-protection findings [2, 14] are mechanistically interesting, but they cannot be read as evidence that MgT prevents or reverses Alzheimer’s disease in humans. Not yet.
We don’t know the optimal dose or duration. Studies have used 1g/day [10] and 2g/day [1, 8]. We don’t know if longer supplementation produces compounding benefits or whether effects plateau. The NR2B research [12] is largely preclinical, and the optimal dose for upregulating this pathway in the human brain is unknown.
The sleep data is conflicted in places. One trial found objective sleep improvements [10]; another largely didn’t [1]. The populations, doses, and duration differed, which probably explains the discrepancy, but we don’t yet have enough data to say with confidence which sleep outcomes MgT most reliably improves and in whom.
The comparison with other forms is incomplete. MAT looks interesting in animal research [3, 4], but without human trials, we can’t say whether it will outperform MgT in practice. And magnesium glycinate, which has its own strong supporters for sleep, hasn’t been head-to-head compared to MgT in a human trial.
Here’s what a sensible, informed person should actually do with this evidence.
Magnesium L-threonate is the most brain-targeted form of magnesium we currently have meaningful human data for. The mechanism is plausible, the animal evidence is consistent and mechanistically rich, and the human trials, while limited in scale, are pointing in a genuine direction: better working memory, faster reaction time, improved sleep quality, and measurable reductions in physiological stress markers. The 7.5-year reduction in estimated cognitive age from a six-week trial is a headline number that deserves more investigation, but it’s from a real, peer-reviewed RCT, not a marketing claim [1].
Magnesium is water-soluble. Excess is excreted. At the doses used in trials (1–2g of MgT daily, delivering roughly 144mg of elemental magnesium), there is no meaningful toxicity risk in healthy adults [1, 10]. You don’t need a blood test to start. Magnesium deficiency is genuinely common, up to half of adults in Western populations don’t meet recommended intakes, and the cognitive and sleep costs of low magnesium are real [5].
If you’re over 40 and you care about your brain, the practical logic is straightforward: standard magnesium supplements may support general health but are unlikely to raise brain magnesium meaningfully. MgT was designed specifically for that purpose. The evidence is promising, not definitive, but promising enough to act on.
Take it daily. Morning or evening, the sleep trial used evening dosing [10], the cognition trial didn’t specify a timing requirement [1]. Give it at least six weeks before judging, which is the minimum duration used in the human trials. Don’t expect miracles. Do expect, on the available evidence, a modest but real improvement in mental sharpness, memory, and the quality of your sleep, particularly if your sleep has been problematic.
One last thought: MgT is one part of the picture. The 2018 animal study [6] found it worked synergistically with environmental enrichment, cognitively stimulating activity. That’s not a surprise, and it’s not a reason to wait until you’re doing everything perfectly. It’s a reason to supplement *and* use your brain, read, learn, connect, move. The research consistently shows that these things work better together.
[1] The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial (2025). *Frontiers in Nutrition*. DOI: 10.3389/fnut.2025.1729164 | https://pubmed.ncbi.nlm.nih.gov/41601871/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12832366/
[2] Magnesium-L-threonate Ameliorates Cognitive Deficit by Attenuating Adult Hippocampal Neurogenesis Impairment in a Mouse Model of Alzheimer’s Disease (2025). *Experimental Neurobiology*. DOI: 10.5607/en24030 | https://pubmed.ncbi.nlm.nih.gov/40234095/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069926/
[3] Enhanced Neurophysiological Benefits of Magnesium-Acetyl-Taurate Over Magnesium-L-Threonate: A Comparative pre-clinical Study on Bioavailability, Synaptic Plasticity and Cognitive Functions (2026). DOI: 10.1007/s12017-026-08929-6 | https://pubmed.ncbi.nlm.nih.gov/42084749/
[4] Enhanced Neurophysiological Benefits of Magnesium-Acetyl-Taurate Over Magnesium-L-Threonate: A Comparative pre-clinical Study on Bioavailability, Synaptic Plasticity and Cognitive Functions, Results section (2026). DOI: 10.1007/s12017-026-08929-6 | https://pubmed.ncbi.nlm.nih.gov/42084749/
[5] Magnesium (Mg2+): Essential Mineral for Neuronal Health: From Cellular Biochemistry to Cognitive Health and Behavior Regulation (2024). DOI: 10.2174/0113816128321466240816075041 | https://pubmed.ncbi.nlm.nih.gov/39253923/
[6] Magnesium boosts the memory restorative effect of environmental enrichment in Alzheimer’s disease mice (2018). DOI: 10.1111/cns.12775 | https://pubmed.ncbi.nlm.nih.gov/29125684/
[7] The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial (2025). *Frontiers in Nutrition*. DOI: 10.3389/fnut.2025.1729164 | https://pubmed.ncbi.nlm.nih.gov/41601871/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12832366/
[8] A Magtein®, Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults (2022). *Nutrients*. DOI: 10.3390/nu14245235 | https://pubmed.ncbi.nlm.nih.gov/36558392/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786204/
[9] Enhancement of learning and memory by elevating brain magnesium (2010). *Neuron*. https://pubmed.ncbi.nlm.nih.gov/20152124/
[10] Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial (2024). *Sleep Medicine: X*. DOI: 10.1016/j.sleepx.2024.100121 | https://pubmed.ncbi.nlm.nih.gov/39252819/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11381753/
[11] Magnesium supplement enhances spatial-context pattern separation and prevents fear overgeneralization (2013). https://pubmed.ncbi.nlm.nih.gov/23764903/
[12] Targeting the NMDA receptor subunit NR2B for treating or preventing age-related memory decline (2014). DOI: 10.1517/14728222.2014.941286 | https://pubmed.ncbi.nlm.nih.gov/25152202/
[13] Neurobehavioral and biochemical effects of magnesium chloride (MgCl2), magnesium sulphate (MgSO4) and magnesium-L-threonate (MgT) supplementation in rats: A dose dependent comparative study (2019). https://pubmed.ncbi.nlm.nih.gov/30829204/
[14] Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer’s disease mouse model (2014). *Molecular Brain*. DOI: 10.1186/s13041-014-0065-y | https://pubmed.ncbi.nlm.nih.gov/25213836/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172865/
[15] Effects of elevation of brain magnesium on fear conditioning, fear extinction, and synaptic plasticity in the infralimbic prefrontal cortex and lateral amygdala (2011). *The Journal of Neuroscience*. https://pubmed.ncbi.nlm.nih.gov/22016520/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Standard curcumin supplements are poorly absorbed by your body because curcumin doesn’t dissolve well in water and is
Quick Read Your gut bacteria and brain communicate through a direct pathway. When you eat prebiotic fibre, your gut bacteria
The nutrients that matter, the forms that work, and the claims to ignore.
